The rate of obesity in adults continues to increase. Obesity affects overall health and is associated with an increased risk for diabetes, high blood pressure, coronary artery disease, osteoarthritis, and sleep apnea. To date, the medication options to treat obesity have been limited.
This study will examine if a new investigational drug, ATHX-105 phosphate, may cause weight loss in humans over a 12-week period.
